Cytokinetics Names Robert Califf, M.D., to Board of Directors
Feb 12, 2018 12:30 pm UTC| Business
SOUTH SAN FRANCISCO, Calif., Feb. 12, 2018 -- Cytokinetics, Incorporated (Nasdaq:CYTK) today announced that Robert Califf, M.D., has been appointed to the company’s Board of Directors. Dr. Califf is the Vice Chancellor...
Conatus Pharmaceuticals to Host Expert Call on Unmet Need in HCV-SVR Patients
Feb 12, 2018 12:30 pm UTC| Business
SAN DIEGO, Feb. 12, 2018 -- Conatus Pharmaceuticals Inc. (NASDAQ:CNAT) will host a conference call and webcast presentation at 12:00 p.m. ET on Tuesday, February 20, with liver disease expert Paul Pockros, M.D.,...
Feb 12, 2018 12:17 pm UTC| Business
Link to the complete 4th Quarter 2017 report: http://hugin.info/201/R/2168042/834731.pdf Hamilton, Bermuda, February, 12 2018 Highlights: We expect the tanker market to turn for the better in 2018. The...
Studio City Announces Extension of Development Period of Its Land Concession
Feb 12, 2018 12:06 pm UTC| Business
MACAU, Feb. 12, 2018 -- Studio City, the Hollywood-inspired, cinematically-themed resort, today announces that the Macau government has granted an extension of the development period under the Studio City land...
Optometry Market will rise at a tepid 4.1% CAGR by 2025, globally: Transparency Market Research
Feb 12, 2018 12:03 pm UTC| Business
Albany, NY, Feb. 12, 2018 -- Our recent report on the global optometry market shows that it will rise at a tepid 4.1% CAGR between 2017 and 2025. At this pace, the market which was valued at US$55.974 bn in 2016, will...
Evogene Financial Results for the Fourth Quarter and Full Year 2017 Earnings Announcement Schedule
Feb 12, 2018 12:01 pm UTC| Business
REHOVOT, Israel, Feb. 12, 2018 -- Evogene Ltd. (NASDAQ:EVGN)(TASE:EVGN), a leading biotechnology company developing novel products for life science markets through the use of a unique computational predictive biology...
Codexis to Present at the 25th International Molecular Medicine Tri-Conference
Feb 12, 2018 12:01 pm UTC| Business
REDWOOD CITY, Calif., Feb. 12, 2018 -- Codexis, Inc. (NASDAQ:CDXS), a leading protein engineering company, announces that John Nicols, President CEO, will discuss the development of an improved DNA ligase for the...